Komori
Earnings3417OHKI HEALTHCARE HOLDINGS CO.,LTD.Trading & Wholesale

Financial Results for the Fiscal Year Ending March 2026 (Japanese GAAP) (Consolidated)

Net sales increased 3.1% year on year, while operating income fell 74.0% and ordinary income fell 50.8%, resulting in a substantial decline in earnings. For the next fiscal year, the Company will not disclose a full-year earnings forecast due to higher costs and supply uncertainty arising from the situation in the Middle East and other factors.

Worth reading
36Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
-74
Year-on-year change in operating income (%)
Wording
Avoiding a definitive answer
How definitive the wording is.

Results for this period

Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAP
Net Sales360,358¥ millionYear on year +3.1%
Operating profit719¥ millionYear on year -74.0%
Ordinary income1,964¥ millionYear on year -50.8%
Net income attributable to owners of the parent1,339¥ millionYear on year -49.2%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.

Net income per share¥98.23
Operating MarginCurrent fiscal year 0.2% / Previous period 0.8%
Financial position at period-end
Total assets148,393¥ million
of which net assets 34,166 ¥ millionEquity ratio 23.0%vs. prior year-end +0.8pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Cash inflows and outflows
Operating-1,415
Investment-671
Financials+1,420
Net change-666

Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.

Cash and cash equivalents at end of period¥2,213 million
Outlook and shareholder returns
Full-year earnings forecast
Net SalesNot disclosed
Operating profitNot disclosed
Ordinary incomeNot disclosed
Net incomeNot disclosed
RemarksThe Company will refrain from providing a consolidated full-year earnings forecast due to turmoil in the Middle East, the resulting surge in raw material, materials and transportation costs, and supply instability.
Annual Dividend Forecast¥26 → ¥30
Payout ratio30.5%
Shareholder Return PolicyThe basic policy is to continue paying stable dividends, with dividends determined after taking into consideration business performance and future business development. Numerical target: Not disclosed.
Factors Behind Changes in Business Performance

The factors were a trend toward declining total demand due to population decline, slower healthcare demand resulting from price increases for products and the domestic inflationary trend, a review of transaction terms due to consolidation among major retail companies, delays in passing price increases for products handled by the Company through to customers, continued increases in labor and logistics costs, increased upfront investment burdens for digitization and systems, temporary costs associated with relocating head office functions, and inventory processing at a subsidiary.

Disclosure regarding the going concern assumption

Not applicable.

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNewly included: 0 companies; excluded: 0 companies (no material change in the scope of consolidation during the period)
Material subsequent eventsNot applicable.
Breakdown of extraordinary income (loss)Extraordinary income Item Gain on sale of non-current assets / Amount ¥2 million, Item Gain on sale of investment securities / Amount ¥491 million / Extraordinary loss Item Loss on Disposal of Fixed Assets / Amount ¥12 million, Item Impairment loss on investment securities / Amount ¥28 million, Item Provision for allowance for doubtful accounts / Amount ¥194 million, Item Impairment Losses on Shares of Affiliates / Amount ¥1 million, Item Other / Amount ¥0 million
Depreciation and amortization¥450 million
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingYes (for analysts)
Issued Shares at Period-End14,072,100 shares
Treasury Shares at Period-End430,824 shares
Results for this period
ItemDetails
Fiscal Period ClassificationFull year
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 April 2025–31 March 2026
Net Sales¥360,358 million (YoY +3.1%)
Operating profit¥719 million (YoY -74.0%)
Ordinary income¥1,964 million (YoY -50.8%)
Profit attributable to owners of the parent¥1,339 million (YoY -49.2%)
Net income per share¥98.23
Operating MarginCurrent fiscal year 0.2% / Previous period 0.8%
Equity ratioEnd of the current fiscal period 23.0% / End of previous period 22.2%
Total assets¥148,393 million
Net assets¥34,166 million
Cash flows from operating activities¥-1,415 million
Cash flows from investing activities¥-671 million
Cash flows from financing activities¥1,420 million
Cash and cash equivalents at end of period¥2,213 million
Full-year earnings forecastNet Sales Not disclosed / Operating profit Not disclosed / Ordinary income Not disclosed / Net income Not disclosed / Remarks The Company will refrain from providing a consolidated full-year earnings forecast due to turmoil in the Middle East, the resulting surge in raw material, materials and transportation costs, and supply instability.
Annual Dividend Forecast¥26 → ¥30
Payout ratio30.5%
Shareholder Return PolicyThe basic policy is to continue paying stable dividends, with dividends determined after taking into consideration business performance and future business development. Numerical target: Not disclosed.
Depreciation and amortization¥450 million
Breakdown of extraordinary income (loss)Extraordinary income Item Gain on sale of non-current assets / Amount ¥2 million, Item Gain on sale of investment securities / Amount ¥491 million / Extraordinary loss Item Loss on Disposal of Fixed Assets / Amount ¥12 million, Item Impairment loss on investment securities / Amount ¥28 million, Item Provision for allowance for doubtful accounts / Amount ¥194 million, Item Impairment Losses on Shares of Affiliates / Amount ¥1 million, Item Other / Amount ¥0 million
Disclosure regarding the going concern assumptionNot applicable.
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNewly included: 0 companies; excluded: 0 companies (no material change in the scope of consolidation during the period)
Material subsequent eventsNot applicable.
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingYes (for analysts)
Issued Shares at Period-End14,072,100 shares
Treasury Shares at Period-End430,824 shares
Factors Behind Changes in Business PerformanceThe factors were a trend toward declining total demand due to population decline, slower healthcare demand resulting from price increases for products and the domestic inflationary trend, a review of transaction terms due to consolidation among major retail companies, delays in passing price increases for products handled by the Company through to customers, continued increases in labor and logistics costs, increased upfront investment burdens for digitization and systems, temporary costs associated with relocating head office functions, and inventory processing at a subsidiary.
Items this document does not state (6)
Revision to Earnings ForecastSegment revenueSegment profitRegional salesOrders received and order backlogImpairment loss

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The decline was due to a downturn in total demand resulting from population decline, slower healthcare demand, a review of transaction terms with major retail companies, delays in passing price increases through to customers, higher labor and logistics costs, upfront investment in digitization and systems, temporary costs associated with relocating head office functions, and inventory processing at subsidiaries.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results for the Fiscal Year Ending March 2026 (Japanese GAAP) (Consolidated) | OHKI HEALTHCARE HOLDINGS CO.,LTD. (3417) timely disclosure | Komori